May 31, 2023 / 03:00PM GMT
Yaron Benjamin Werber - TD Cowen, Research Division - MD & Senior Biotechnology Analyst
So good morning, everybody, and thank you, once again, for joining us at the 4th Annual Oncology Innovation Summit. I'm Yaron Werber, one of the biotech analysts here at TD Cowen, and it's a great pleasure to moderate the next session with Amgen.
With us today is David Reese, EVP of R&D; and Arvind Sood, Vice President of Investor Relations. Gentlemen, thank you so much for joining us. It's good to see you.
David M. Reese - Amgen Inc. - EVP of Research & Development
Thanks, Yaron. Great to be here.
Yaron Benjamin Werber - TD Cowen, Research Division - MD & Senior Biotechnology Analyst
So for the audience, if you have any questions, feel free to e-mail them directly to me, [email protected]. Or also there is a Wall Street webcasting link, and you can put the questions directly into the box. And I could see them and happy to ask them for you.
Amgen Inc at TD Cowen Oncology Innovation Summit (Virtual) Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers